Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Prexige – COX-2 Inhibitor

Drug (Brand/Generic)

Prexige (lumiracoxib)

Company/Licensee

Novartis

Therapy Class

Selective COX-2 inhibitor

Product Description

Inhibits the action of the COX-2 isoenzyme

Current Indication

Treatment of pain and inflammation

Market Sector

CNS - pain

Development Status

Withdrawn from all major markets
Expand

Go Top